Skip to main content

Advertisement

SpringerLink
Log in

Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

It is well known that the expression level of secretory group IIA phospholipase A2 (sPLA2-IIA) is elevated in inflammatory diseases and lipopolysaccharide (LPS) upregulates the expression of sPLA2-IIA in human umbilical vein endothelial cells (HUVECs). Activated factor X (FXa) is an important enzyme in the coagulation cascade responsible for thrombin generation, and it influences cell signaling in various cell types by activating protease-activated receptors (PARs). Here, FX or FXa was examined for its effects on the expression and activity of sPLA2-IIA in HUVECs and mouse. Prior treatment of cells or mouse with FXa inhibited LPS-induced expression and activity of sPLA2-IIA via interacting with FXa receptor (effective cell protease receptor-1, EPR-1). And FXa suppressed the activation of cytosolic phospholipase A2 (cPLA2) and extracellular signal-regulated kinase (ERK) 1/2 by LPS. Therefore, these results suggest that FXa may inhibit LPS-mediated expression of sPLA2-IIA by suppression of cPLA2 and ERK 1/2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Furie, B., and B.C. Furie. 1988. The molecular basis of blood coagulation. Cell 53: 505–518.

    Article  CAS  PubMed  Google Scholar 

  2. Edgington, T.S., N. Mackman, K. Brand, and W. Ruf. 1991. The structural biology of expression and function of tissue factor. Thrombosis and Haemostasis 66: 67–79.

    CAS  PubMed  Google Scholar 

  3. Ahamed, J., M. Belting, and W. Ruf. 2005. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. Blood 105: 2384–2391.

    Article  CAS  PubMed  Google Scholar 

  4. Davie, E.W., K. Fujikawa, and W. Kisiel. 1991. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30: 10363–10370.

    Article  CAS  PubMed  Google Scholar 

  5. Steinberg, S.F. 2005. The cardiovascular actions of protease-activated receptors. Molecular Pharmacology 67: 2–11.

    Article  CAS  PubMed  Google Scholar 

  6. Ossovskaya, V.S., and N.W. Bunnett. 2004. Protease-activated receptors: contribution to physiology and disease. Physiological Reviews 84: 579–621.

    Article  CAS  PubMed  Google Scholar 

  7. Six, D.A., and E.A. Dennis. 2000. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochimica et Biophysica Acta 1488: 1–19.

    Article  CAS  PubMed  Google Scholar 

  8. Kudo, I., and M. Murakami. 2002. Phospholipase A2 enzymes. Prostaglandins & Other Lipid Mediators 68–69: 3–58.

    Article  Google Scholar 

  9. Hara, S., I. Kudo, H.W. Chang, K. Matsuta, T. Miyamoto, and K. Inoue. 1989. Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis. Journal of Biochemistry 105: 395–399.

    CAS  PubMed  Google Scholar 

  10. Seilhamer, J.J., W. Pruzanski, P. Vadas, et al. 1989. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. Journal of Biological Chemistry 264: 5335–5338.

    CAS  PubMed  Google Scholar 

  11. Menschikowski, M., A. Hagelgans, and G. Siegert. 2006. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins & Other Lipid Mediators 79: 1–33.

    Article  CAS  Google Scholar 

  12. Pruzanski, W., and P. Vadas. 1991. Phospholipase A2–a mediator between proximal and distal effectors of inflammation. Immunology Today 12: 143–146.

    CAS  PubMed  Google Scholar 

  13. Waydhas, C., D. Nast-Kolb, K.H. Duswald, P. Lehnert, and L. Schweiberer. 1989. Prognostic value of serum phospholipase A in the multitraumatized patient. Klinische Wochenschrift 67: 203–206.

    Article  CAS  PubMed  Google Scholar 

  14. Nakano, T., O. Ohara, H. Teraoka, and H. Arita. 1990. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. Journal of Biological Chemistry 265: 12745–12748.

    CAS  PubMed  Google Scholar 

  15. Oka, S., and H. Arita. 1991. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. Journal of Biological Chemistry 266: 9956–9960.

    CAS  PubMed  Google Scholar 

  16. Crowl, R.M., T.J. Stoller, R.R. Conroy, and C.R. Stoner. 1991. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. Journal of Biological Chemistry 266: 2647–2651.

    CAS  PubMed  Google Scholar 

  17. Bae, J.S., W. Lee, J.O. Nam, J.E. Kim, S.W. Kim, and I.S. Kim. 2014. Transforming growth factor beta-induced protein promotes severe vascular inflammatory responses. American Journal of Respiratory and Critical Care Medicine 189: 779–786.

    Article  PubMed  Google Scholar 

  18. Wang, H., H. Liao, M. Ochani, et al. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 10: 1216–1221.

    Article  CAS  PubMed  Google Scholar 

  19. Rittirsch, D., M.S. Huber-Lang, M.A. Flierl, and P.A. Ward. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nature Protocols 4: 31–36.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Menschikowski, M., A. Hagelgans, B. Heyne, et al. 2005. Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells. Biochimica et Biophysica Acta 1733: 157–171.

    Article  CAS  PubMed  Google Scholar 

  21. Bae, J.S., and A.R. Rezaie. 2010. Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms. Thrombosis Research 125: e9–e15.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Shimoyama, Y., R. Sakamoto, T. Akaboshi, M. Tanaka, and K. Ohtsuki. 2001. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro. Biological and Pharmaceutical Bulletin 24: 1004–1008.

    Article  CAS  PubMed  Google Scholar 

  23. Alaoui-El-Azher, M., Y. Wu, N. Havet, A. Israel, A. Lilienbaum, and L. Touqui. 2002. Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways. Molecular Pharmacology 61: 786–794.

    Article  CAS  PubMed  Google Scholar 

  24. Kuwata, H., C. Fujimoto, E. Yoda, et al. 2007. A novel role of group VIB calcium-independent phospholipase A2 (iPLA2gamma) in the inducible expression of group IIA secretory PLA2 in rat fibroblastic cells. Journal of Biological Chemistry 282: 20124–20132.

    Article  CAS  PubMed  Google Scholar 

  25. Flynn, J.T., and H. Hoff 3rd. 1995. Lipopolysaccharide induces time-dependent increases in prostaglandin H synthase-2 and cytosolic phospholipase A2 mRNA in cultured human microvessel-derived endothelial cells. Shock 4: 433–440.

    CAS  PubMed  Google Scholar 

  26. Goldblum, S.E., T.W. Brann, X. Ding, J. Pugin, and P.S. Tobias. 1994. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. Journal of Clinical Investigation 93: 692–702.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Russell, J.A. 2006. Management of sepsis. New England Journal of Medicine 355: 1699–1713.

    Article  CAS  PubMed  Google Scholar 

  28. Baluk, P., L.C. Yao, J. Feng, et al. 2009. TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. Journal of Clinical Investigation 119: 2954–2964.

    PubMed Central  CAS  PubMed  Google Scholar 

  29. Mehta, D., and A.B... Malik. 2006. Signaling mechanisms regulating endothelial permeability. Physiological Reviews 86: 279–367.

  30. Buras, J.A., B. Holzmann, and M. Sitkovsky. 2005. Animal models of sepsis: setting the stage. Nature Reviews Drug Discovery 4: 854–865.

    Article  CAS  PubMed  Google Scholar 

  31. Harris, S.G., J. Padilla, L. Koumas, D. Ray, and R.P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends in Immunology 23: 144–150.

    Article  CAS  PubMed  Google Scholar 

  32. Natarajan, G., M. Glibetic, V. Raykova, J.P. Ofenstein, R.L. Thomas, and J.V. Aranda. 2007. Nitric oxide and prostaglandin response to group B streptococcal infection in the lung. Annals of Clinical and Laboratory Science 37: 170–176.

    CAS  PubMed  Google Scholar 

  33. Agard, M., S. Asakrah, and L.A. Morici. 2013. PGE(2) suppression of innate immunity during mucosal bacterial infection. Front Cell Infect Microbiol 3: 45.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Leslie, C.C. 1997. Properties and regulation of cytosolic phospholipase A2. Journal of Biological Chemistry 272: 16709–16712.

    Article  CAS  PubMed  Google Scholar 

  35. Clark, J.D., A.R. Schievella, E.A. Nalefski, and L.L. Lin. 1995. Cytosolic phospholipase A2. Journal of Lipid Mediators and Cell Signalling 12: 83–117.

    Article  CAS  PubMed  Google Scholar 

  36. Sano, H., X. Zhu, A. Sano, et al. 2001. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of cytosolic phospholipase A2 is essential for human eosinophil adhesion to fibronectin. Journal of Immunology 166: 3515–3521.

    Article  CAS  Google Scholar 

  37. Bosetti, F., and G.R. Weerasinghe. 2003. The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse. Journal of Neurochemistry 87: 1471–1477.

    Article  CAS  PubMed  Google Scholar 

  38. Johann, S., E. Kampmann, B. Denecke, et al. 2008. Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation. Journal of Molecular Neuroscience 34: 177–185.

    Article  CAS  PubMed  Google Scholar 

  39. Balsinde, J., M.A. Balboa, P.A. Insel, and E.A. Dennis. 1999. Regulation and inhibition of phospholipase A2. Annual Review of Pharmacology and Toxicology 39: 175–189.

    Article  CAS  PubMed  Google Scholar 

  40. Bradley, J.D., A.A. Dmitrienko, A.J. Kivitz, et al. 2005. A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. Journal of Rheumatology 32: 417–423.

    CAS  PubMed  Google Scholar 

  41. Tanaka, K., T. Kato, K. Matsumoto, and T. Yoshida. 1993. Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy. Inflammation 17: 107–119.

    Article  CAS  PubMed  Google Scholar 

  42. Vadas, P., W. Pruzanski, J. Kim, and V. Fornasier. 1989. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. American Journal of Pathology 134: 807–811.

    PubMed Central  CAS  PubMed  Google Scholar 

  43. Zeiher, B.G., J. Steingrub, P.F. Laterre, A. Dmitrienko, Y. Fukiishi, and E. Abraham. 2005. LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Critical Care Medicine 33: 1741–1748.

    Article  CAS  PubMed  Google Scholar 

  44. Grass, D.S., R.H. Felkner, M.Y. Chiang, et al. 1996. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. Journal of Clinical Investigation 97: 2233–2241.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Beck, G., B.A. Yard, J. Schulte, et al. 2003. Secreted phospholipases A2 induce the expression of chemokines in microvascular endothelium. Biochemical and Biophysical Research Communications 300: 731–737.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the National Research Foundation of Korea (NRF) funded by the Korean government [MSIP] (grant no. 2013-067053).

Conflict of interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan, 712-715, Republic of Korea

    Sae-Kwang Ku

  2. College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu, 702-701, Republic of Korea

    Jong-Sup Bae

Authors
  1. Sae-Kwang Ku
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong-Sup Bae
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jong-Sup Bae.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ku, SK., Bae, JS. Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2 . Inflammation 38, 987–994 (2015). https://doi.org/10.1007/s10753-014-0062-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-0062-4

KEY WORDS

Search

Navigation